These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 19384760)
1. [Development of conjunctival hyperemia with the use of a fixed combination of latanoprost/timolol: systematic review and meta-analysis of clinical trials]. Vinuesa-Silva JM; Vinuesa-Silva I; Pinazo-Durán MD; Soto-Alvarez J; Delgado-Ortega L; Díaz-Cerezo S Arch Soc Esp Oftalmol; 2009 Apr; 84(4):199-207. PubMed ID: 19384760 [TBL] [Abstract][Full Text] [Related]
2. Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials. Honrubia F; García-Sánchez J; Polo V; de la Casa JM; Soto J Br J Ophthalmol; 2009 Mar; 93(3):316-21. PubMed ID: 19019922 [TBL] [Abstract][Full Text] [Related]
3. A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma. Parmaksiz S; Yüksel N; Karabas VL; Ozkan B; Demirci G; Caglar Y Eur J Ophthalmol; 2006; 16(1):73-80. PubMed ID: 16496249 [TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of the efficacy and safety of latanoprost, travoprost and the fixed combination timolol-dorzolamide; a prospective, randomized, masked, cross-over design study. Chiseliţă D; Antohi I; Medvichi R; Danielescu C Oftalmologia; 2005; 49(3):39-45. PubMed ID: 16408674 [TBL] [Abstract][Full Text] [Related]
5. Comparison of brimonidine/latanoprost and timolol/dorzolamide: two randomized, double-masked, parallel clinical trials. Zabriskie N; Netland PA; Adv Ther; 2003; 20(2):92-100. PubMed ID: 12836809 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of prostaglandin-timolol fixed combinations: a meta-analysis of randomized clinical trials. Aptel F; Cucherat M; Denis P Eur J Ophthalmol; 2012; 22(1):5-18. PubMed ID: 22167538 [TBL] [Abstract][Full Text] [Related]
7. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Netland PA; Landry T; Sullivan EK; Andrew R; Silver L; Weiner A; Mallick S; Dickerson J; Bergamini MV; Robertson SM; Davis AA; Am J Ophthalmol; 2001 Oct; 132(4):472-84. PubMed ID: 11589866 [TBL] [Abstract][Full Text] [Related]
8. Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs. Eisenberg DL; Toris CB; Camras CB Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S105-15. PubMed ID: 12204706 [TBL] [Abstract][Full Text] [Related]
9. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension. Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466 [TBL] [Abstract][Full Text] [Related]
10. A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension. Topouzis F; Melamed S; Danesh-Meyer H; Wells AP; Kozobolis V; Wieland H; Andrew R; Wells D Eur J Ophthalmol; 2007; 17(2):183-90. PubMed ID: 17415690 [TBL] [Abstract][Full Text] [Related]
11. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension. Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448 [TBL] [Abstract][Full Text] [Related]
12. A randomized, prospective study of bimatoprost 0.01% or travoprost/timolol in patients previously treated with latanoprost and timolol to reduce intraocular pressure. Nixon DR J Ocul Pharmacol Ther; 2013 Dec; 29(10):876-81. PubMed ID: 24070367 [TBL] [Abstract][Full Text] [Related]
13. Hyperemia reduction after administration of a fixed combination of bimatoprost and timolol maleate to patients on prostaglandin or prostamide monotherapy. Paranhos A; Mendonça M; Silva MJ; Giampani J; Torres RJ; Della Paolera M; Russ H; Lottenberg CL J Ocul Pharmacol Ther; 2010 Dec; 26(6):611-5. PubMed ID: 21029020 [TBL] [Abstract][Full Text] [Related]
14. Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials. Li N; Chen XM; Zhou Y; Wei ML; Yao X Clin Exp Ophthalmol; 2006 Nov; 34(8):755-64. PubMed ID: 17073898 [TBL] [Abstract][Full Text] [Related]
15. Efficiency of travoprost versus fixed-combination latanoprost/timolol. Soto J Clin Drug Investig; 2009; 29(8):557; author reply 558. PubMed ID: 19591517 [No Abstract] [Full Text] [Related]
16. Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study. Katz LJ; Rauchman SH; Cottingham AJ; Simmons ST; Williams JM; Schiffman RM; Hollander DA Curr Med Res Opin; 2012 May; 28(5):781-8. PubMed ID: 22458918 [TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of randomized controlled trials comparing latanoprost with other glaucoma medications in chronic angle-closure glaucoma. Li J; Lin X; Yu M Eur J Ophthalmol; 2015; 25(1):18-26. PubMed ID: 25044139 [TBL] [Abstract][Full Text] [Related]
18. Systematic review of intraocular pressure-lowering effects of adjunctive medications added to latanoprost. Cheng JW; Li Y; Wei RL Ophthalmic Res; 2009; 42(2):99-105. PubMed ID: 19546601 [TBL] [Abstract][Full Text] [Related]
19. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Camras CB Am J Ophthalmol; 2002 May; 133(5):732; author reply 732-3. PubMed ID: 11992888 [No Abstract] [Full Text] [Related]
20. Concomitant administration of travoprost and brinzolamide versus fixed latanoprost/timolol combined therapy: three-month comparison of efficacy and safety. Martinez-de-la-Casa JM; Castillo A; Garcia-Feijoo J; Mendez-Hernandez C; Fernandez-Vidal A; Garcia-Sanchez J Curr Med Res Opin; 2004 Sep; 20(9):1333-9. PubMed ID: 15383180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]